start portlet menu bar end portlet menu bar

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O1 in European sea bass fry and juveniles

Strona główna Wiedza Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O1 in European sea bass fry and juveniles

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O1 in European sea bass fry and juveniles

European Sea Bass (Dicentrarchus labrax) is a marine fish species with a high commercial value, especially in the Mediterranean countries and Europe. Vibriosis caused by Listonella (Vibrio) anguillarum is a common disease in Sea Bass that has led to significant economic losses to date. Therefore, development and use of preventive strategies can evade these associated mortalities.

Pobierz ten artykuł

4,66 MB

O tym artykule

Autorzy

Ruiz, M. C.; Robles, R.; Callol, C.; Colomer, S.; Vendrell, D.; Perelló, M. Bermúdez, L.

Streszczenie

Clear differences in the mortality rates between vaccinated and control groups were observed. The mortality rates reported in vaccinated groups ranged between 0 and 18.52 % whereas the mortality rates in control groups were of 68-97 %. Deaths were observed between 48 and 96 hours after challenge.

Powiązane usługi

HIPRA Diagnos

Powiązane produkty

ICTHIOVAC® VR

Udostępnij na

start portlet menu bar

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O1 in European sea bass fry and juveniles

Display portlet menu
end portlet menu bar

Patrz także

Publikacje

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass ...

26-05-2016
Streszczenia choroby

Lactococcosis in trout

12-01-2017
Aktualności

HIPRA presents ICTHIOVAC® VR/PD vaccine in Greece

27-03-2018